Product Information
AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT is a brand product labeled by Mannkind Corporation, priced at $7.8585 per EA under NDC 47918088018. Its NADAC has been published 106 times since Jun 19, 2024.
Manufacturer
Mannkind CorporationNDC
47918088018
Classification
Brand
Dosage Form
KIT
Route
RESPIRATORY (INHALATION)
Last Updated
4/1/2026
Approval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
7/1/2016
Price Statistics
The NADAC for AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT has been published 106 times since Jun 19, 2024, and over the history we have for it it has risen 8.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8585 per EA |
|---|---|
| All-time high | $7.8585 (Jun 24, 2026) |
| All-time low | $7.2217 (Jun 19, 2024) |
| 52-week high | $7.8585 |
| 52-week low | $7.5825 |
| Median price | $7.5895 |
| Average price | $7.5473 |
| Largest weekly change | +5.0% (Dec 18, 2024) |
| Weeks tracked | 106 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT, manufactured by Mannkind Corporation, is $7.8585 per EA (NDC 47918088018), effective Jun 24, 2026.
How has the price of AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT changed over time?
Over the history we have for it, the NADAC for AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT has risen 8.8%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT?
Since Jun 19, 2024, the NADAC for AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT has ranged from a low of $7.2217 (Jun 19, 2024) to a high of $7.8585 (Jun 24, 2026), with a median of $7.5895 per EA.
Are there cheaper alternatives to AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT, but none are currently priced below it.
Who manufactures AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT?
AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT (NDC 47918088018) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification